Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
03/26/2024 - 10:25
PHARMANUTRA
Avviso di deposito documentazione / Notice of publication of documents
03/25/2024 - 17:26
PHARMANUTRA
PHN: Avviso di deposito documentazione/Notice of publication of documents
03/15/2024 - 17:46
PHARMANUTRA
BoD approves draft statutory financial statements and consolidated annual financial statement at Decembre 31, 2023
03/15/2024 - 17:45
PHARMANUTRA
CdA approva il progetto di bilancio e la relazione finanziaria annuale consolidata al 31 dicembre 2023
02/26/2024 - 18:00
PHARMANUTRA
PHN - Approvazione del Progetto di fusione
02/26/2024 - 17:50
PHARMANUTRA
PHN - Approval of the merger plan
01/11/2024 - 17:44
PHARMANUTRA
PR - PHN PRELIMINARY REVENUES 2023
01/11/2024 - 17:42
PHARMANUTRA
PHN - RICAVI PRELIMINARI 2023
01/08/2024 - 17:36
PHARMANUTRA
PHN: Perdita qualifica PMI - Loss of SME status
12/21/2023 - 15:24
PHARMANUTRA
PR Financial Calendar 2024
12/21/2023 - 15:21
PHARMANUTRA
CS Calendario Finanziario 2024
12/20/2023 - 11:08
PHARMANUTRA
Comunicazione di cessazione patto parasociale
11/10/2023 - 12:06
PHARMANUTRA
INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023
11/10/2023 - 12:04
PHARMANUTRA
CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023
11/08/2023 - 10:56
PHARMANUTRA
Allegato 3F - Ottobre 2023
11/06/2023 - 17:52
PHARMANUTRA
PHN - The BoD approved the Interim consolidated financial report as at 30 September 2023
11/06/2023 - 17:49
PHARMANUTRA
PHN - Il CdA approva il Resoconto Intermedio di Gestione al 30 settembre 2023
10/10/2023 - 18:17
PHARMANUTRA
PHN - Initiation of share buy-back program
10/10/2023 - 18:16
PHARMANUTRA
PHN - Avvio programma azioni proprie
10/03/2023 - 18:05
PHARMANUTRA
PR - FIRST SALES ON THE US MARKET
10/03/2023 - 18:00
PHARMANUTRA
CS - PRIME VENDITE SUL MERCATO AMERICANO
09/19/2023 - 10:12
PHARMANUTRA
Half-Year Financial Report as of 30 June 2023
09/19/2023 - 10:10
PHARMANUTRA
PHN-Pubblicazione della Relazione Finanziaria Semestrale al 30 giugno 2023
09/11/2023 - 17:50
PHARMANUTRA
FIRST HALF 2023 RESULTS

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are